Regeneron says its COVID-19 drug cut patient visits

  • By cvbizz
  • October 29, 2020
  • 0
  • 29 Views
Share This Post!

Regeneron said its coronavirus antibody cocktail that was used to treat President Trump significantly reduced medical visits in a trial of nearly 800 patients

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en


Upstate News Headlines

PHP Code Snippets Powered By : XYZScripts.com